Maryland Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,465
| Closed | -$491K | – | 251 |
|
|
2022
Q1 | $491K | Buy |
5,465
+45
| +0.8% | +$4.04K | 0.03% | 164 |
|
|
2021
Q4 | $607K | Hold |
5,420
| – | – | 0.03% | 151 |
|
|
2021
Q3 | $681K | Hold |
5,420
| – | – | 0.04% | 141 |
|
|
2021
Q2 | $734K | Hold |
5,420
| – | – | 0.04% | 136 |
|
|
2021
Q1 | $735K | Sell |
5,420
-135
| -2% | -$18.3K | 0.05% | 131 |
|
|
2020
Q4 | $782K | Hold |
5,555
| – | – | 0.06% | 118 |
|
|
2020
Q3 | $619K | Hold |
5,555
| – | – | 0.05% | 123 |
|
|
2020
Q2 | $622K | Buy |
5,555
+600
| +12% | +$67.2K | 0.06% | 118 |
|
|
2020
Q1 | $384K | Buy |
+4,955
| New | +$384K | 0.05% | 149 |
|